Form 4: Johnson & Johnson Executive Kathryn E. Wengel Reports Stock Option and Restricted Share Unit Awards

Kathryn E. Wengel, EVP, Chief TO and Risk Officer of Johnson & Johnson, reports the acquisition of stock options and restricted share units under the company's Long-Term Incentive Plan.

Summary

• On February 15, 2025, Kathryn E. Wengel, EVP, Chief TO and Risk Officer of Johnson & Johnson, was granted stock options for 30,841 shares at an exercise price of $156.15.
• These options vest in three equal annual installments starting on the first anniversary of the grant date and expire on February 15, 2035.
• Wengel also received 1,903 restricted share units (RSUs) that vest in three equal annual installments beginning on the first anniversary of the grant date.
• These RSUs convert into shares of common stock on a one-for-one basis upon vesting.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing detailing executive compensation. It is neutral in tone and reflects standard corporate practices.

Positives

• The grant of stock options and RSUs aligns the executive's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Future Outlook

The document does not contain any specific forward-looking statements beyond the vesting schedules of the stock options and RSUs.

Industry Context

This Form 4 filing is a routine disclosure of executive compensation in the form of stock options and restricted share units, which is a common practice among publicly traded companies to incentivize and retain key personnel.

Comparison to Industry Standards

• Stock option and RSU grants are standard components of executive compensation packages in the pharmaceutical and healthcare industries.
• Companies like Pfizer (PFE), Merck (MRK), and AbbVie (ABBV) also utilize similar equity-based compensation plans to align executive incentives with shareholder value.
• The vesting schedules and grant sizes are generally comparable to industry norms for executives at similar levels.

Stakeholder Impact

• The grant of stock options and RSUs may have a minor positive impact on shareholder sentiment as it aligns executive interests with shareholder value.

Key Dates

Keywords

stock options, restricted share units, JNJ, Johnson & Johnson, executive compensation, Form 4, insider trading